Exopharm

CY 2019 ASX Announcements

23/05/2019 – Upcoming Release of Shares from Escrow

22/05/2019 – Acceleration of Development Activities

30/04/2019 – March 2019 Quarterly Activities Report and Appendix 4C

09/04/2019 – Investor Presentation

01/04/2019 – April 2019 Market Update

27/03/2019 – Explainer: The critical bottleneck of exosome isolation and the power of Exopharm’s LEAP technology

21/02/2019 – Dec 2018 Half-Yearly Report and Appendix 4D

05/02/2019 – Positive outcomes from initial animal studies of Plexaris and Exomeres

31/01/2018 – January 2019 Quarterly Cash Flow Report

31/01/2019 – December 2018 Quarterly Activities Report

CY 2018 ASX Announcements

28/12/2018 – Investor Deck

18/12/2018 – Initial Director Interests x 3

18/12/2018 – Closes Initial Public Offering Fully Subscribed and Lists on the ASX

14/12/2018 – Capital Structure and Restricted Securities

14/12/2018 – Securities Trading Policy

14/12/2018 – Updated Pro-Forma and Commitments

14/12/2018 – Financial Statements – Year Ended 30 June 2018

14/12/2018 – Financial Statements – Year Ended 30 June 2017

14/12/2018 – Financial Statements – Year Ended 30 June 2016

14/12/2018 – Constitution

14/12/2018 – Prospectus

14/12/2018 – Appendix 1A and Information Form and Checklist

14/12/2018 – Top 20 Holders

14/12/2018 – Distribution Schedule

14/12/2018 – ASX Notice – Admission to the Official List